BioFluidica is a privately held biotechnology company that has developed a diagnostic platform allowing for disease management and diagnosis through prognosis, all from a simple blood test.

Biotechnology

BioFluidica

Mateusz Hupert

Doug Paulin

Steven A. Soper

The executive team at BioFluidica has experience in a variety of industries, including board directorship, lung association management, and biochemistry. They have also been educated at some of the top universities in the world, including Pierre and Marie Curie University and Oregon State University.

CEO and Executive Team

About

Team members

Other teams at BioFluidica

Leadership Team

Board of Directors